This interview-based study compared 51 treatment-seeking children with ARFID, finding that younger patients (0-5 years) had more preterm births and pre- and perinatal complications, while older patients (6-17 years) had more mental comorbidities.
Journal of Eating Disorders · 7 authors, 5 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This interview-based study compared 51 treatment-seeking children with ARFID, finding that younger patients (0-5 years) had more preterm births and pre- and perinatal complications, while older patients (6-17 years) had more mental comorbidities.
Medical records and diagnostic interviews revealed that younger patients were significantly more likely to have been born preterm, experience pre- and perinatal complications, and undergo postnatal invasive procedures. They also presented with significantly more physical comorbidities, particularly congenital anomalies. Conversely, older patients had significantly higher rates of mental comorbidities, especially mood disorders. Exploratory analyses of ARFID diagnostic criteria and main presentations showed medium-sized differences between age groups, with sensory sensitivity being the most common presentation across both. The findings suggest age-specific characteristics that could be relevant for diagnosis and treatment planning.